Increasing Coverage in Mass Drug Administration for Lymphatic Filariasis Elimination in an Urban Setting: a Study of Malindi Town, Kenya

被引:39
|
作者
Njomo, Doris W. [1 ]
Mukoko, Dunstan A. [2 ]
Nyamongo, Nipher K. [1 ]
Karanja, Joan [3 ]
机构
[1] Kenya Med Res Inst KEMRI, Eastern & Southern Africa Ctr Int Parasite Contro, Nairobi, Kenya
[2] Minist Hlth, Div Vector Borne & Neglected Trop Dis, Nairobi, Kenya
[3] Minist Hlth, Malindi Dist Hosp, Malindi, Kenya
来源
PLOS ONE | 2014年 / 9卷 / 01期
基金
比尔及梅琳达.盖茨基金会;
关键词
DIETHYLCARBAMAZINE; PROGRAM; ALBENDAZOLE; IVERMECTIN; INFECTION; INDIA;
D O I
10.1371/journal.pone.0083413
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Implementation of Mass Drug Administration (MDA) in urban settings is an obstacle to Lymphatic Filariasis (LF) elimination. No urban-specific guidelines on MDA in urban areas exist. Malindi district urban area had received 4 MDA rounds by the time the current study was implemented. Programme data showed average treatment coverage of 28.4% (2011 MDA), far below recommended minimum of 65-80%. Methods: To identify, design and test strategies for increased treatment coverage in urban areas, a quasi-experimental study was conducted in Malindi urban area. Three sub-locations with lowest treatment coverage in 2011 MDA were purposively selected. In the pre-test phase, 947 household heads sampled using systematic random method were interviewed for quantitative data. For qualitative data, 12 Focus Group Discussions (FGDs) with single sex adult and youth male and female groups and 3 with community drug distributors (CDDs) were conducted. Forty in-depth interviews with opinion leaders and self-administered questionnaires with District Public Health officers purposively selected were carried out. The quantitative data were analyzed using SPSS version 16 and statistical significance assessed by x(2) test. The qualitative data were analyzed manually according to study's themes. Results and Discussion: The identified strategies were implemented prior to and during 2012 MDA in two sub-locations (experimental) while in the third (control), usual MDA strategies were applied. In the post-test phase, 2012 MDA coverage in experimental and control sub-locations was comparatively assessed for effect of the newly designed strategies on urban MDA. Results indicated improved treatment coverage in experimental sub-locations, 77.1% in Shella and 66.0% in Barani. Central (control) sub-location also attained high coverage, 70.4% indicating average treatment coverage of 71%. Conclusion: The identified strategies contributed to increased treatment coverage in experimental sites and should be applied in urban areas. Due to closeness of sites, spillover effects may have contributed to increased coverage in the control site.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] A study on coverage, compliance and awareness about mass drug administration for elimination of lymphatic filariasis in a district of West Bengal, India
    Karmakar, P. Ray
    Mitra, K.
    Chatterjee, Anirban
    Jana, P. K.
    Bhattacharya, S.
    Lahiri, S. K.
    JOURNAL OF VECTOR BORNE DISEASES, 2011, 48 (02) : 101 - 104
  • [22] MONITORING COVERAGE OF LYMPHATIC FILARIASIS MASS DRUG ADMINISTRATION (MDA) IN TANZANIA
    Damas, Deogratias
    Erasto, Paul
    Chikawe, Maria
    Uisso, Cecilia
    Mwingira, Upendo
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (04): : 324 - 325
  • [23] Compliance and efficacy of mass drug administration for elimination of lymphatic filariasis in Egypt
    El Setouhy, Maged
    Aziz, Khaled Abdel
    Ahmed, Ehab S.
    Ramzy, Reda M.
    Weil, Gary J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 176 - 176
  • [24] Towards elimination of Lymphatic Filariasis in Kenya: improving advocacy, communication and social mobilization activities for mass drug administration, a qualitative study
    Kibe, Lydiah W.
    Kimani, Bridget W.
    Okoyo, Collins
    Omondi, Wyckliff P.
    Sultani, Hadley M.
    Njomo, Doris W.
    TROPICAL DISEASES TRAVEL MEDICINE AND VACCINES, 2022, 8 (01)
  • [25] Towards elimination of Lymphatic Filariasis in Kenya: improving advocacy, communication and social mobilization activities for mass drug administration, a qualitative study
    Lydiah W. Kibe
    Bridget W. Kimani
    Collins Okoyo
    Wyckliff P. Omondi
    Hadley M. Sultani
    Doris W. Njomo
    Tropical Diseases, Travel Medicine and Vaccines, 8
  • [26] Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
    Khaemba, Christabel
    Barry, Abbie
    Omondi, Wyckliff P.
    Bota, Kefa
    Matendechero, Sultani
    Wandera, Cecilia
    Siyoi, Fred
    Kirui, Elvis
    Oluka, Margaret
    Nambwa, Pamela
    Gurumurthy, Parthasarathi
    Njenga, Sammy M.
    Guantai, Anastacia
    Aklillu, Eleni
    PHARMACEUTICALS, 2021, 14 (03)
  • [27] Coverage and Awareness of and Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis in Burdwan District, West Bengal, India
    Roy, Rabindra Nath
    Sarkar, Aditya Prasad
    Misra, Raghunath
    Chakroborty, Amitava
    Mondal, Tusar Kanti
    Bag, Kanad
    JOURNAL OF HEALTH POPULATION AND NUTRITION, 2013, 31 (02) : 171 - 177
  • [28] Coverage of mass drug administration (MDA) and operational issues in elimination of lymphatic filariasis in selected districts of Jharkhand, India
    Kumar, Dhananjay
    Kumar, Anil
    Vikas, Kumar
    Kumar, Chandramani
    Sircar, Shubhashish
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2023, 12 (01) : 111 - 116
  • [29] No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds
    Yaya Ibrahim Coulibaly
    Moussa Sangare
    Housseini Dolo
    Lamine Soumaoro
    Siaka Yamoussa Coulibaly
    Ilo Dicko
    Abdoul Fatao Diabaté
    Lamine Diarra
    Michel Emmanuel Coulibaly
    Salif Seriba Doumbia
    Abdallah Amadou Diallo
    Massitan Dembele
    Benjamin G. Koudou
    Moses John Bockarie
    Louise A. Kelly-Hope
    Amy D. Klion
    Thomas B. Nutman
    Parasitology Research, 2022, 121 : 3243 - 3248
  • [30] No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds
    Coulibaly, Yaya Ibrahim
    Sangare, Moussa
    Dolo, Housseini
    Soumaoro, Lamine
    Coulibaly, Siaka Yamoussa
    Dicko, Ilo
    Diabate, Abdoul Fatao
    Diarra, Lamine
    Coulibaly, Michel Emmanuel
    Doumbia, Salif Seriba
    Diallo, Abdallah Amadou
    Dembele, Massitan
    Koudou, Benjamin G.
    Bockarie, Moses John
    Kelly-Hope, Louise A.
    Klion, Amy D.
    Nutman, Thomas B.
    PARASITOLOGY RESEARCH, 2022, 121 (11) : 3243 - 3248